 | • レポートコード：GIR201101869 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ブデソニドの世界市場を調査対象にし、ブデソニドの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（注射用懸濁液、エアロゾル、吸入パウダー、錠剤、カプセル）、用途別分析（呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：AstraZeneca、Orion Corporation、Sandoz、Teva、Chiesi Farmaceutici、Mylan、Synmosa Biopharma、Salix、Cosmo Pharmaceuticals、Cipla、Lunan Better Pharma、Shanghai Sine Promod ・メーカー別販売量、売上、市場シェア ・ブデソニドの地域別市場分析 ・ブデソニドの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ブデソニドのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ブデソニドのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ブデソニドの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ブデソニドの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ブデソニドの種類別市場規模2015-2020：注射用懸濁液、エアロゾル、吸入パウダー、錠剤、カプセル ・ブデソニドの用途別市場規模2015-2020：呼吸器疾患治療、鼻疾患治療、炎症性腸疾患治療、その他 ・ブデソニドの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Budesonide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Budesonide market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 8796.1 million by 2025, from USD 7767.5 million in 2019.
Market segmentation
Budesonide market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Budesonide market has been segmented into
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
By Application, Budesonide has been segmented into:
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Budesonide market presented in the report. This section sheds light on the sales growth of different regional and country-level Budesonide markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Budesonide market.
The report offers in-depth assessment of the growth and other aspects of the Budesonide market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Budesonide Market Share Analysis
Budesonide competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Budesonide sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Budesonide sales, revenue and market share for each player covered in this report.
The major players covered in Budesonide are:
AstraZeneca
Orion Corporation
Sandoz
Teva
Chiesi Farmaceutici
Mylan
Synmosa Biopharma
Salix
Cosmo Pharmaceuticals
Cipla
Lunan Better Pharma
Shanghai Sine Promod
Among other players domestic and global, Budesonide market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Budesonide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Budesonide, with price, sales, revenue and global market share of Budesonide in 2018 and 2019.
Chapter 3, the Budesonide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Budesonide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Budesonide market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Budesonide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Budesonide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Budesonide Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Injectable Suspension
1.2.3 Aerosols
1.2.4 Inhalation Powder
1.2.5 Tablet and Capsule
1.3 Market Analysis by Application
1.3.1 Overview: Global Budesonide Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Others
1.4 Overview of Global Budesonide Market
1.4.1 Global Budesonide Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Orion Corporation
2.2.1 Orion Corporation Details
2.2.2 Orion Corporation Major Business
2.2.3 Orion Corporation SWOT Analysis
2.2.4 Orion Corporation Product and Services
2.2.5 Orion Corporation Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sandoz
2.3.1 Sandoz Details
2.3.2 Sandoz Major Business
2.3.3 Sandoz SWOT Analysis
2.3.4 Sandoz Product and Services
2.3.5 Sandoz Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Chiesi Farmaceutici
2.5.1 Chiesi Farmaceutici Details
2.5.2 Chiesi Farmaceutici Major Business
2.5.3 Chiesi Farmaceutici SWOT Analysis
2.5.4 Chiesi Farmaceutici Product and Services
2.5.5 Chiesi Farmaceutici Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Mylan
2.6.1 Mylan Details
2.6.2 Mylan Major Business
2.6.3 Mylan Product and Services
2.6.4 Mylan Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Synmosa Biopharma
2.7.1 Synmosa Biopharma Details
2.7.2 Synmosa Biopharma Major Business
2.7.3 Synmosa Biopharma Product and Services
2.7.4 Synmosa Biopharma Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Salix
2.8.1 Salix Details
2.8.2 Salix Major Business
2.8.3 Salix Product and Services
2.8.4 Salix Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cosmo Pharmaceuticals
2.9.1 Cosmo Pharmaceuticals Details
2.9.2 Cosmo Pharmaceuticals Major Business
2.9.3 Cosmo Pharmaceuticals Product and Services
2.9.4 Cosmo Pharmaceuticals Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Cipla
2.10.1 Cipla Details
2.10.2 Cipla Major Business
2.10.3 Cipla Product and Services
2.10.4 Cipla Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Lunan Better Pharma
2.11.1 Lunan Better Pharma Details
2.11.2 Lunan Better Pharma Major Business
2.11.3 Lunan Better Pharma Product and Services
2.11.4 Lunan Better Pharma Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Shanghai Sine Promod
2.12.1 Shanghai Sine Promod Details
2.12.2 Shanghai Sine Promod Major Business
2.12.3 Shanghai Sine Promod Product and Services
2.12.4 Shanghai Sine Promod Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Budesonide Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Budesonide Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Budesonide Manufacturer Market Share in 2019
3.3.2 Top 6 Budesonide Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Budesonide Sales, Revenue and Market Share by Regions
4.1.1 Global Budesonide Sales and Market Share by Regions (2015-2020)
4.1.2 Global Budesonide Revenue and Market Share by Regions (2015-2020)
4.2 North America Budesonide Sales and Growth Rate (2015-2020)
4.3 Europe Budesonide Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Budesonide Sales and Growth Rate (2015-2020)
4.5 South America Budesonide Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Budesonide Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Budesonide Sales, Revenue and Market Share by Country
5.1.1 North America Budesonide Sales and Market Share by Country (2015-2020)
5.1.2 North America Budesonide Revenue and Market Share by Country (2015-2020)
5.2 United States Budesonide Sales and Growth Rate (2015-2020)
5.3 Canada Budesonide Sales and Growth Rate (2015-2020)
5.4 Mexico Budesonide Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Budesonide Sales, Revenue and Market Share by Country
6.1.1 Europe Budesonide Sales and Market Share by Country (2015-2020)
6.1.2 Europe Budesonide Revenue and Market Share by Country (2015-2020)
6.2 Germany Budesonide Sales and Growth Rate (2015-2020)
6.3 UK Budesonide Sales and Growth Rate (2015-2020)
6.4 France Budesonide Sales and Growth Rate (2015-2020)
6.5 Russia Budesonide Sales and Growth Rate (2015-2020)
6.6 Italy Budesonide Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Budesonide Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Budesonide Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Budesonide Revenue and Market Share by Regions (2015-2020)
7.2 China Budesonide Sales and Growth Rate (2015-2020)
7.3 Japan Budesonide Sales and Growth Rate (2015-2020)
7.4 Korea Budesonide Sales and Growth Rate (2015-2020)
7.5 India Budesonide Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Budesonide Sales and Growth Rate (2015-2020)
7.7 Australia Budesonide Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Budesonide Sales, Revenue and Market Share by Country
8.1.1 South America Budesonide Sales and Market Share by Country (2015-2020)
8.1.2 South America Budesonide Revenue and Market Share by Country (2015-2020)
8.2 Brazil Budesonide Sales and Growth Rate (2015-2020)
8.3 Argentina Budesonide Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Budesonide Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Budesonide Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Budesonide Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Budesonide Sales and Growth Rate (2015-2020)
9.3 Turkey Budesonide Sales and Growth Rate (2015-2020)
9.4 Egypt Budesonide Sales and Growth Rate (2015-2020)
9.5 South Africa Budesonide Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Budesonide Sales and Market Share by Type (2015-2020)
10.2 Global Budesonide Revenue and Market Share by Type (2015-2020)
10.3 Global Budesonide Price by Type (2015-2020)
11 Global Budesonide Market Segment by Application
11.1 Global Budesonide Sales Market Share by Application (2015-2020)
11.2 Global Budesonide Revenue Market Share by Application (2015-2020)
11.3 Global Budesonide Price by Application (2015-2020)
12 Market Forecast
12.1 Global Budesonide Sales, Revenue and Growth Rate (2021-2025)
12.2 Budesonide Market Forecast by Regions (2021-2025)
12.2.1 North America Budesonide Market Forecast (2021-2025)
12.2.2 Europe Budesonide Market Forecast (2021-2025)
12.2.3 Asia-Pacific Budesonide Market Forecast (2021-2025)
12.2.4 South America Budesonide Market Forecast (2021-2025)
12.2.5 Middle East & Africa Budesonide Market Forecast (2021-2025)
12.3 Budesonide Market Forecast by Type (2021-2025)
12.3.1 Global Budesonide Sales Forecast by Type (2021-2025)
12.3.2 Global Budesonide Market Share Forecast by Type (2021-2025)
12.4 Budesonide Market Forecast by Application (2021-2025)
12.4.1 Global Budesonide Sales Forecast by Application (2021-2025)
12.4.2 Global Budesonide Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Budesonide Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Budesonide by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Budesonide Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Budesonide Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Budesonide Major Business
Table 10. AstraZeneca Budesonide Total Revenue (USD Million) (2018-2019)
Table 11. AstraZeneca SWOT Analysis
Table 12. AstraZeneca Budesonide Product and Services
Table 13. AstraZeneca Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 15. Orion Corporation Budesonide Major Business
Table 16. Orion Corporation Budesonide Total Revenue (USD Million) (2018-2019)
Table 17. Orion Corporation SWOT Analysis
Table 18. Orion Corporation Budesonide Product and Services
Table 19. Orion Corporation Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Sandoz Basic Information, Manufacturing Base and Competitors
Table 21. Sandoz Budesonide Major Business
Table 22. Sandoz Budesonide Total Revenue (USD Million) (2018-2019)
Table 23. Sandoz SWOT Analysis
Table 24. Sandoz Budesonide Product and Services
Table 25. Sandoz Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Teva Basic Information, Manufacturing Base and Competitors
Table 27. Teva Budesonide Major Business
Table 28. Teva Budesonide Total Revenue (USD Million) (2018-2019)
Table 29. Teva SWOT Analysis
Table 30. Teva Budesonide Product and Services
Table 31. Teva Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 33. Chiesi Farmaceutici Budesonide Major Business
Table 34. Chiesi Farmaceutici Budesonide Total Revenue (USD Million) (2018-2019)
Table 35. Chiesi Farmaceutici SWOT Analysis
Table 36. Chiesi Farmaceutici Budesonide Product and Services
Table 37. Chiesi Farmaceutici Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Mylan Basic Information, Manufacturing Base and Competitors
Table 39. Mylan Budesonide Major Business
Table 40. Mylan Budesonide Total Revenue (USD Million) (2018-2019)
Table 41. Mylan SWOT Analysis
Table 42. Mylan Budesonide Product and Services
Table 43. Mylan Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Synmosa Biopharma Basic Information, Manufacturing Base and Competitors
Table 45. Synmosa Biopharma Budesonide Major Business
Table 46. Synmosa Biopharma Budesonide Total Revenue (USD Million) (2018-2019)
Table 47. Synmosa Biopharma SWOT Analysis
Table 48. Synmosa Biopharma Budesonide Product and Services
Table 49. Synmosa Biopharma Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Salix Basic Information, Manufacturing Base and Competitors
Table 51. Salix Budesonide Major Business
Table 52. Salix Budesonide Total Revenue (USD Million) (2018-2019)
Table 53. Salix SWOT Analysis
Table 54. Salix Budesonide Product and Services
Table 55. Salix Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 57. Cosmo Pharmaceuticals Budesonide Major Business
Table 58. Cosmo Pharmaceuticals Budesonide Total Revenue (USD Million) (2018-2019)
Table 59. Cosmo Pharmaceuticals SWOT Analysis
Table 60. Cosmo Pharmaceuticals Budesonide Product and Services
Table 61. Cosmo Pharmaceuticals Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Cipla Basic Information, Manufacturing Base and Competitors
Table 63. Cipla Budesonide Major Business
Table 64. Cipla Budesonide Total Revenue (USD Million) (2018-2019)
Table 65. Cipla SWOT Analysis
Table 66. Cipla Budesonide Product and Services
Table 67. Cipla Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Lunan Better Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Lunan Better Pharma Budesonide Major Business
Table 70. Lunan Better Pharma Budesonide Total Revenue (USD Million) (2018-2019)
Table 71. Lunan Better Pharma SWOT Analysis
Table 72. Lunan Better Pharma Budesonide Product and Services
Table 73. Lunan Better Pharma Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Shanghai Sine Promod Basic Information, Manufacturing Base and Competitors
Table 75. Shanghai Sine Promod Budesonide Major Business
Table 76. Shanghai Sine Promod Budesonide Total Revenue (USD Million) (2018-2019)
Table 77. Shanghai Sine Promod SWOT Analysis
Table 78. Shanghai Sine Promod Budesonide Product and Services
Table 79. Shanghai Sine Promod Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Global Budesonide Sales by Manufacturer (2018-2019) (M Units)
Table 81. Global Budesonide Revenue by Manufacturer (2018-2019) (USD Million)
Table 82. Global Budesonide Sales by Regions (2015-2020) (M Units)
Table 83. Global Budesonide Sales Market Share by Regions (2015-2020)
Table 84. Global Budesonide Revenue by Regions (2015-2020) (USD Million)
Table 85. North America Budesonide Sales by Countries (2015-2020) (M Units)
Table 86. North America Budesonide Sales Market Share by Countries (2015-2020)
Table 87. North America Budesonide Revenue by Countries (2015-2020) (USD Million)
Table 88. North America Budesonide Revenue Market Share by Countries (2015-2020)
Table 89. Europe Budesonide Sales by Countries (2015-2020) (M Units)
Table 90. Europe Budesonide Sales Market Share by Countries (2015-2020)
Table 91. Europe Budesonide Revenue by Countries (2015-2020) (USD Million)
Table 92. Asia-Pacific Budesonide Sales by Regions (2015-2020) (M Units)
Table 93. Asia-Pacific Budesonide Sales Market Share by Regions (2015-2020)
Table 94. Asia-Pacific Budesonide Revenue by Regions (2015-2020) (USD Million)
Table 95. South America Budesonide Sales by Countries (2015-2020) (M Units)
Table 96. South America Budesonide Sales Market Share by Countries (2015-2020)
Table 97. South America Budesonide Revenue by Countries (2015-2020) (USD Million)
Table 98. South America Budesonide Revenue Market Share by Countries (2015-2020)
Table 99. Middle East & Africa Budesonide Sales by Countries (2015-2020) (M Units)
Table 100. Middle East & Africa Budesonide Sales Market Share by Countries (2015-2020)
Table 101. Middle East & Africa Budesonide Revenue by Countries (2015-2020) (USD Million)
Table 102. Middle East & Africa Budesonide Revenue Market Share by Countries (2015-2020)
Table 103. Global Budesonide Sales by Type (2015-2020) (M Units)
Table 104. Global Budesonide Sales Share by Type (2015-2020)
Table 105. Global Budesonide Revenue by Type (2015-2020) (USD Million)
Table 106. Global Budesonide Revenue Share by Type (2015-2020)
Table 107. Global Budesonide Sales by Application (2015-2020) (M Units)
Table 108. Global Budesonide Sales Share by Application (2015-2020)
Table 109. Global Budesonide Sales Forecast by Regions (2021-2025) (M Units)
Table 110. Global Budesonide Market Share Forecast by Regions (2021-2025)
Table 111. Global Budesonide Sales Forecast by Type (2021-2025) (M Units)
Table 112. Global Budesonide Market Share Forecast by Type (2021-2025)
Table 113. Global Budesonide Sales Forecast by Application (2021-2025)
Table 114. Global Budesonide Market Share Forecast by Application (2021-2025)
Table 115. Direct Channel Pros & Cons
Table 116. Indirect Channel Pros & Cons
Table 117. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Budesonide Picture
Figure 2. Global Sales Market Share of Budesonide by Type in 2019
Figure 3. Injectable Suspension Picture
Figure 4. Aerosols Picture
Figure 5. Inhalation Powder Picture
Figure 6. Tablet and Capsule Picture
Figure 7. Budesonide Sales Market Share by Application in 2019
Figure 8. Respiratory Disease Treatment Picture
Figure 9. Nose Disease Treatment Picture
Figure 10. Inflammatory Bowel Disease Treatment Picture
Figure 11. Others Picture
Figure 12. Global Budesonide Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Budesonide Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Budesonide Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Budesonide Sales Market Share by Manufacturer in 2019
Figure 33. Global Budesonide Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Budesonide Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Budesonide Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 38. Global Budesonide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Budesonide Revenue Market Share by Regions (2015-2020)
Figure 40. Global Budesonide Revenue Market Share by Regions in 2018
Figure 41. North America Budesonide Sales and Growth Rate (2015-2020)
Figure 42. Europe Budesonide Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Budesonide Sales and Growth Rate (2015-2020)
Figure 44. South America Budesonide Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Budesonide Sales and Growth Rate (2015-2020)
Figure 46. North America Budesonide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Budesonide Sales Market Share by Countries (2015-2020)
Figure 48. North America Budesonide Sales Market Share by Countries in 2018
Figure 49. North America Budesonide Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Budesonide Revenue Market Share by Countries in 2018
Figure 51. United States Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 52. Canada Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 53. Mexico Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 54. Europe Budesonide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Budesonide Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Budesonide Revenue Market Share by Countries in 2019
Figure 57. Germany Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 58. UK Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 59. France Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 60. Russia Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 61. Italy Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 62. Asia-Pacific Budesonide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Budesonide Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Budesonide Revenue Market Share by Regions 2019
Figure 65. China Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 66. Japan Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 67. Korea Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 68. India Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 69. Southeast Asia Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 70. South America Budesonide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Budesonide Sales Market Share by Countries in 2019
Figure 72. South America Budesonide Revenue Market Share by Countries in 2019
Figure 73. Brazil Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 74. Argentina Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 75. Middle East and Africa Budesonide Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Budesonide Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Budesonide Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Budesonide Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 80. Egypt Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 81. Turkey Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 82. South Africa Budesonide Sales and Growth Rate (2015-2020) (M Units)
Figure 83. Global Budesonide Sales and Growth Rate (2021-2025) (M Units)
Figure 84. Global Budesonide Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Budesonide Market Forecast (2021-2025) (M Units)
Figure 86. Europe Sales Budesonide Market Forecast (2021-2025) (M Units)
Figure 87. Asia-Pacific Sales Budesonide Market Forecast (2021-2025) (M Units)
Figure 88. South America Sales Budesonide Market Forecast (2021-2025) (M Units)
Figure 89. Middle East & Africa Sales Budesonide Market Forecast (2021-2025) (M Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
レイノー病治療の世界市場 2020年 Market Overview The global Raynauds Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Raynauds Disease T…- ポンペ病治療の世界市場 2020年 Market Overview The global Pompe Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1052.4 million by 2025, from USD 972.6 million in 2019. The Pompe Disease…
- 末期腎臓病治療の世界市場 2020年 Market Overview The global End-Stage Kidney Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The End-Stage …
- 人獣共通感染症治療の世界市場 2020年 Market Overview The global Zoonotic Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Zoonotic Disease T…
- カナバン病治療薬の世界市場 2020年 Market Overview The global Canavan Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canavan Disease …